Epileptic Encephalopathy

Kv7 Activation.
Our Approach to Epileptic Encephalopathy

Knopp is committed to tackling tough problems in rare pediatric epilepsies. Our approach is augmenting the function of Kv7 channels.

Scroll to discover

Our Goal is to Discover and Develop Best-in-Class Kv7.2/7.3 Activators

for the treatment of epilepsy and other disorders of the central nervous system. In order to do that, we would like to stay in touch with you.

Knopp Biosciences A Biotechnology Company Seeking to Improve Patients' Lives